Gilead Sciences (GILD) Reports a Low Quality Beat/Raise, PT to $86 at Raymond James
Tweet Send to a Friend
Raymond James analyst Steven Seedhouse raised the price target on Gilead Sciences (NASDAQ: GILD) to $86.00 (from $83.00) after ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
